Eli Lilly & Co's Form 4 filing
Sigilon Therapeutics, Inc. (SGTX) · filed Aug 14, 2023
- Accession no.
- 0000899243-23-018115
- Filed
- Aug 14, 2023, 4:30 PM ET
- Trade date
- Aug 11, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $25.6M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eli Lilly & CoCIK 0000059478 | 10% Owner |
| Shenandoah Acquisition CorpCIK 0001983165 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +1,718,493 | $14.92 | +$25,639,915.56 | 100 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.